SEC Filing Summary for Abbott Laboratories (ABT)

This SEC filing details a transaction involving Michael F. Roman, a director at Abbott Laboratories. On April 24, 2026, Mr. Roman was granted an award of 2,286 restricted stock units under the company's 2026 Incentive Stock Program. These units are set to be paid out on a one-to-one basis in Abbott common shares. The payout will occur upon the earlier of Mr. Roman's separation from service, death, or a change in control, as defined by the Program. Following this award, Mr. Roman's total ownership of common shares stands at 10,764. The transaction code "A" indicates an acquisition, and the price per share is reported as 0.0, consistent with a stock award. The filing was signed on April 28, 2026.